The Future of T1D Autoantibody Screening
The type 1 diabetes (T1D) community has collectively identified a need for general population autoantibody screening. In response, a report…
T1D Exchange at ADCES21: The Impact of Hypoglycemia & Glucagon
This week, we are excited to present three posters at ADCES Annual Conference. These posters focus on different aspects of…
T1D Exchange Registry: What We’ve Learned over the Last 2 Years
We’re continuing to celebrate 2 years of the T1D Exchange Registry! In honor of our 2nd anniversary, we’re sharing insights…
What We Learned from the Online Community in July 2021
We learn something new every day from the T1D Exchange Online Community’s Question of the Day responses. This month, it…
Celebrating 2 Years of the T1D Exchange Registry
We’re celebrating 2 years of the T1D Exchange Registry! For the 2nd anniversary of the Registry, we want to show…
July 2021 Clinical Diabetes Special Collection: T1D Exchange QIC
In the July 2021 edition of Clinical Diabetes, T1D Exchange is featured in a special collection of articles about the…
Top Questions of the Day – June 2021
What We Learned from the Online Community This Month Thank you to every member of the T1D Exchange Online Community…
A Look Inside the FDA’s Review Processes for Medical Devices
Learn the difference between the terms FDA-cleared and FDA- approved Understand the categories and pathway for FDA review for Class…
Top Questions of the Day – May 2021
What We Learned from the Online Community This Month Thank you to every member of the T1D Exchange Online Community…
Innovations in T1D Tech: Highlights from the ATTD Conference
Every year the Advanced Technologies & Treatments for Diabetes (ATTD) conference brings together diabetes researchers from all over the world….
